Targeting Alzheimer's disease genes with RNA interference: An efficient strategy for silencing mutant alleles

Nucleic Acids Research

Volumn 32, Issue 2, 2004, Pages 661-668

  Miller, Victor M ^a   Gouvion, Cynthia M ^a   Davidson, Beverly L ^a   Paulson, Henry L ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; RNA POLYMERASE; SMALL INTERFERING RNA; TAU PROTEIN;

ALLELE; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE CONSTRUCT; GENE IDENTIFICATION; GENE MUTATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MONKEY; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; RNA SEQUENCE; RNA SYNTHESIS; RNA TRANSCRIPTION; WESTERN BLOTTING;

ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BASE SEQUENCE; COS CELLS; DNA-DIRECTED RNA POLYMERASES; GENES, REPORTER; HELA CELLS; HUMANS; MUTATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SUBSTRATE SPECIFICITY; TAU PROTEINS; VIRAL PROTEINS;

EID: 1342306385     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkh208     Document Type: Article

References (29)

1. McManus,M.T. and Sharp,P.A. (2002) Gene silencing in mammals by small interfering RNAs. Nature Rev. Genet., 3, 737-747.
2. Song,E., Lee,S.K., Wang,J., Ince,N., Ouyang,N., Min,J., Chen,J., Shankar,P. and Lieberman,J. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nature Med., 9, 347-351.
3. Miller,V.M., Xia,H., Marrs,G.L., Gouvion,C.M., Lee,G., Davidson,B.L. and Paulson,H.L. (2003) Allele-specific silencing of dominant disease genes. Proc. Natl Acad. Sci. USA, 100, 7195-7200.
4. Gonzalez-Alegre,P., Miller,V.M., Davidson,B.L. and Paulson,H.L. (2003) Toward therapy for DYT1 dystonia: allele-specific silencing of mutant TorsinA. Ann. Neurol., 53, 781-787.
5. Ding,H., Schwarz,D.S., Keene,A., Affar,B., Fenton,L., Xia,X., Shi,Y., Zamore,P.D. and Xu,Z. (2003) Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell, 2, 209-217.
6. Abdelgany,A., Wood,M. and Beeson,D. (2003) Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference. Hum. Mol. Genet., 12, 2637-2644.
7. Martinez,L.A., Naguibneva,I., Lehrmann,H., Vervisch,A., Tchenio,T., Lozano,G. and Harel-Bellan,A. (2002) Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc. Natl Acad. Sci. USA, 99, 14849-14854.
8. Hardy,J. and Selkoe,D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297, 353-356.
9. Lee,V.M., Goedert,M. and Trojanowski,J.Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci., 24, 1121-1159.
10. Mullan,M., Crawford,F., Axelman,K., Houlden,H., Lilius,L., Winblad,B. and Lannfelt,L. (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nature Genet., 1, 345-347.
11. Poorkaj,P., Bird,T.D., Wijsman,E., Nemens,E., Garruto,R.M., Anderson,L., Andreadis,A., Wiederholt,W.C., Raskind,M. and Schellenberg,G. (1998) Ann. Neurol., 43, 815-825.
12. Hutton,M., Lendon,C.L., Rizzu,P., Baker,M., Froelich,S., Houlden,H., Pickering-Brown,S., Chakraverty,S., Isaacs,A. et al. (1998) Nature, 393, 702-705.
13. Lewis,J., Dickson,D.W., Lin,W.L., Chisholm,L., Corral,A., Jones,G., Yen,S.H., Sahara,N., Skipper,L., Yager,D., Eckman,C., Hardy,J., Hutton,M. and McGowan,E. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science, 293, 1487-1491.
14. Oddo,S., Caccamo,A., Shepherd,J.D., Murphy,M.P., Golde,T.E., Kayed,R., Metherate,R., Mattson,M.P., Akbari,Y. and LaFerla,F.M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron, 39, 409-421.
15. Houlden,H., Baker,M., Morris,H.R., MacDonald,N., Pickering-Brown,S., Adamson,J., Lees,A.J., Rossor,M.N., Quinn,N.P., Kertesz,A., Khan,M.N., Hardy,J., Lantos,P.L., St George-Hyslop,P., Munoz,D.G., Mann,D., Lang,A.E., Bergeron,C., Bigio,E.H., Litvan,I., Bhatia,K.P., Dickson,D., Wood,N.W. and Hutton,M. (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology, 56, 1702-1706.
16. Donze,O. and Picard,D. (2002) RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. Nucleic Acids Res., 30, e46.
17. Koseki,S., Tanabe,T., Tani,K., Asano,S., Shioda,T., Nagai,Y., Shimada,T., Ohkawa,J. and Taira,K. (1999) Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III. J. Virol., 73, 1868-1877.
18. Kawasaki,H. and Taira,K. (2003) Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res., 31, 700-707.
19. Chai,Y., Koppenhafer,S.L., Shoesmith,S.J., Perez,M.K. and Paulson,H.L. (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet., 8, 673-682.
20. Kato,M., Frick,D.N., Lee,J., Tabor,S., Richardson,C.C. and Ellenberger,T. (2001) A complex of the bacteriophage T7 primase-helicase and DNA polymerase directs primer utilization. J. Biol. Chem., 276, 21809-21820.
21. Elbashir,S.M., Harborth,J., Lendeckel,W., Yalcin,A., Weber,K. and Tuschl,T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494-498.
22. Zeng,Y., Yi,R. and Cullen,B.R. (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl Acad. Sci. USA, 100, 9779-9784.
23. Doench,J.G., Petersen,C.P. and Sharp,P.A. (2003) siRNAs can function as miRNAs. Genes Dev., 17, 438-442.
24. Xia,H., Mao,Q., Paulson,H.L. and Davidson,B.L. (2002) siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol., 20, 1006-1010.
25. Schwarz,D.S., Hutvagner,G., Du,T., Xu,Z., Aronin,N. and Zamore,P.D. (2003) Asymmetry in the assembly of the RNAi enzyme complex. Cell, 115, 199-208.
26. Chiu,Y.L. and Rana,T.M. (2002) RNAi in human cells: basic structural and functional features of small interfering RNA. Mol. Cell., 10, 549-561.
27. Sisodia,S.S. and St George-Hyslop,P.H. (2002) gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nature Rev. Neurosci., 3, 281-290
28. Rubinson,D.A., Dillon,C.P., Kwiatkowski,A.V., Sievers,C., Yang,L., Kopinja,J., Rooney,D.L., Ihrig,M.M., McManus,M.T., Gertler,F.B., Scott,M.L. and Van Parijs,L. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genet., 33, 401-406.
29. Davidson,B.L. and Breakefield,X.O. (2003) Viral vectors for gene delivery to the nervous system. Nat. Rev. Neurosci., 4, 353-364.